相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States
William C. Goedel et al.
JAMA NETWORK OPEN (2020)
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder
Sarah E. Wakeman et al.
JAMA NETWORK OPEN (2020)
Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United States
Lewei (Allison) Lin et al.
ANNALS OF FAMILY MEDICINE (2019)
Remission from chronic opioid use Studying environmental and socioeconomic factors on recovery (RECOVER): Study design and participant characteristics
Walter Ling et al.
CONTEMPORARY CLINICAL TRIALS (2019)
County-level access to opioid use disorder medications in medicare Part D (2010-2015)
Amanda J. Abraham et al.
HEALTH SERVICES RESEARCH (2019)
Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder
Rebecca L. Haffajee et al.
JAMA NETWORK OPEN (2019)
Impact of Medicaid Expansion on Access to Opioid Analgesic Medications and Medication-Assisted Treatment
Alana Sharp et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2018)
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality A Cohort Study
Marc R. Larochelle et al.
ANNALS OF INTERNAL MEDICINE (2018)
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
Joshua D. Lee et al.
LANCET (2018)
Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis
Joshua A. Barocas et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2018)
Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study
Michael A. Irvine et al.
LANCET PUBLIC HEALTH (2018)
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population
Jake R. Morgan et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)
Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths
Mahesh K. B. Parmar et al.
ADDICTION (2017)
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
Luis Sordo et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
Luis Sordo et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Public sector low threshold office-based buprenorphine treatment: outcomes at year 7
Elenore Patterson Bhatraju et al.
ADDICTION SCIENCE & CLINICAL PRACTICE (2017)
Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users
B. Nosyk et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial
Andrew J. Saxon et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis
Alexander Y. Walley et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Medication-Assisted Treatment in Criminal Justice Agencies Affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): Availability, Barriers, and Intentions
Peter D. Friedmann et al.
SUBSTANCE ABUSE (2012)
Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study
Michael Soyka et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000
Nina G. Shah et al.
DRUG AND ALCOHOL DEPENDENCE (2006)
Transitions to injecting drug use among noninjecting heroin users - Social network influence and individual susceptibility
A Neaigus et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Distance traveled to outpatient drug treatment and client retention
K Beardsley et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2003)
分享论文
